TrialThe Journal of investigative dermatology2012
Immunomodulation by imiquimod in patients with high-risk primary melanoma.
Rupa Narayan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papertrialcites it